Optimising duration of antiplatelet therapy following acute coronary syndrome.

Topic: Thrombosis and platelets
Organised by The Sahlgrenska Academy - Goteborg University / Course Director: Karl Swedberg / Supported by an unrestricted educational grant from AstraZeneca

About the speaker

Professor Patrick Washington Serruys

National University of Ireland, Galway (Ireland)
14 presentations
0 follower

7 more presentations in this session

Introduction and objectives - Antiplatelet therapy in high-risk patients with ACS.

Speaker: Doctor A. Fernandez Ortiz (Madrid, ES)

Thumbnail

Early initiation of antiplatelet therapy - Recommendations and current practice.

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Discussion - Early initiation of antiplatelet therapy.

Thumbnail

Thienopyridines and ticagrelor – New pharmacological evidence and clinical effects.

Speaker: Professor R. Storey (Sheffield, GB)

Thumbnail

Discussion - Thienopyridines and ticagrelor.

Thumbnail

Access the full session

Antiplatelet therapy in high-risk patients with acute coronary syndromes – Current evidence and future directions

Speakers: Professor P. Serruys, Doctor A. Fernandez Ortiz, Professor P. Steg, Professor R. Storey
Thumbnail

About the event

Image

ESC CONGRESS 2014

30 August - 3 September 2014

Sessions Presentations

This platform is supported by

logo Novo Nordisk